J
Jayalakshmi S. Mysore
Researcher at Harvard University
Publications - 40
Citations - 4550
Jayalakshmi S. Mysore is an academic researcher from Harvard University. The author has contributed to research in topics: Huntington's disease & Trinucleotide repeat expansion. The author has an hindex of 22, co-authored 39 publications receiving 3745 citations.
Papers
More filters
Journal ArticleDOI
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Bin Zhang,Chris Gaiteri,Liviu-Gabriel Bodea,Zhi Wang,Joshua J McElwee,Alexei A. Podtelezhnikov,Chunsheng Zhang,Tao Xie,Linh M. Tran,Radu Dobrin,Eugene M. Fluder,Bruce E. Clurman,Stacey Melquist,Manikandan Narayanan,Christine Suver,Hardik Shah,Milind Mahajan,Tammy Gillis,Jayalakshmi S. Mysore,Marcy E. MacDonald,John Lamb,David A. Bennett,Cliona Molony,David J. Stone,Vilmundur Gudnason,Amanda J. Myers,Eric E. Schadt,Harald Neumann,Jun Zhu,Valur Emilsson +29 more
TL;DR: The causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.
Journal ArticleDOI
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
Jong-Min Lee,Vanessa C. Wheeler,Michael J. Chao,Jean Paul G. Vonsattel,Ricardo Mouro Pinto,Diane Lucente,Kawther Abu-Elneel,Eliana Marisa Ramos,Jayalakshmi S. Mysore,Tammy Gillis,Marcy E. MacDonald,James F. Gusella,Denise Harold,Timothy Stone,Valentina Escott-Price,Jun Han,Alexey Vedernikov,Peter Holmans,Lesley Jones,Seung Kwak,Mithra Mahmoudi,Michael Orth,G. Bernhard Landwehrmeyer,Jane S. Paulsen,E. Ray Dorsey,Ira Shoulson,Richard H. Myers +26 more
TL;DR: It is demonstrated that HD disease modification in humans occurs in nature and offer a genetic route to identifying in-human validated therapeutic targets in this and other Mendelian disorders.
Journal ArticleDOI
Induced Pluripotent Stem Cells from Patients with Huntington’s Disease : Show CAG Repeat-Expansion-Associated Phenotypes
Virginia B. Mattis,Soshana P. Svendsen,Allison D. Ebert,Clive N. Svendsen,Alvin R. King,Malcolm Casale,Sara T. Winokur,Gayani Batugedara,Marquis P. Vawter,Peter J. Donovan,Leslie F. Lock,Leslie M. Thompson,Yu Zhu,Elisa Fossale,Ranjit Singh Atwal,Tammy Gillis,Jayalakshmi S. Mysore,Jian Hong Li,Ihn Sik Seong,Yiping Shen,Xiaoli Chen,Vanessa C. Wheeler,Marcy E. MacDonald,James F. Gusella,Sergey S Akimov,Nicolas Arbez,Tarja A. Juopperi,Tamara Ratovitski,Jason H. Chiang,Woon Roung Kim,Eka Chighladze,Erin Watkin,Chun Zhong,Georgia Makri,Robert N. Cole,Russell L. Margolis,Hongjun Song,Guo Li Ming,Christopher A. Ross,Julia A. Kaye,Julia A. Kaye,Aaron C. Daub,Aaron C. Daub,Punita Sharma,Punita Sharma,Amanda R. Mason,Amanda R. Mason,Steven Finkbeiner,Steven Finkbeiner,Junying Yu,James A. Thomson,David Rushton,Stephen P. Brazier,Alysia Battersby,Amanda Redfern,Hsui Er Tseng,Alexander William John Harrison,Paul J. Kemp,Nicholas D. Allen,Marco Onorati,Valentina Castiglioni,Elena Cattaneo,Jamshid Arjomand +62 more
TL;DR: The generation and characterization of 14 induced pluripotent stem cell (iPSC) lines from HD patients and controls reveal CAG-repeat-expansion-associated gene expression patterns that distinguish patient lines from controls, and early onset versus late onset HD.
Journal ArticleDOI
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
J-M Lee,Eliana Marisa Ramos,Junghee Lee,Tammy Gillis,Jayalakshmi S. Mysore,Michael R. Hayden,Simon C. Warby,Patrick J. Morrison,Martha Nance,Christopher A. Ross,Russell L. Margolis,Ferdinando Squitieri,S. Orobello,S. Di Donato,Estrella Gómez-Tortosa,Carmen Ayuso,Oksana Suchowersky,Ronald J. Trent,Elizabeth McCusker,Andrea Novelletto,Marina Frontali,Randi Jones,Tetsuo Ashizawa,Samuel Frank,Marie Saint-Hilaire,Steven M. Hersch,H. D. Rosas,Diane Lucente,Madeline Harrison,Andrea Zanko,Ruth K. Abramson,Karen Marder,Jorge Sequeiros,J.S. Paulsen,Georg Bernhard Landwehrmeyer,Richard H. Myers,Marcy E. MacDonald,James F. Gusella +37 more
TL;DR: Age at onset of diagnostic motor manifestations in Huntington disease (HD) is strongly correlated with an expanded CAG trinucleotide repeat, and the rate of HD pathogenesis leading to motor diagnosis is determined by a completely dominant action of the longest expanded allele and as yet unidentified genetic or environmental factors.
Journal ArticleDOI
CAG repeat not polyglutamine length determines timing of Huntington’s disease onset
Jongmin Lee,Kevin Correia,Jacob M. Loupe,Kyung Hee Kim,Douglas Barker,Eun Pyo Hong,Michael J. Chao,Jeffrey D. Long,Diane Lucente,Jean Paul G. Vonsattel,Ricardo Mouro Pinto,Kawther Abu Elneel,Eliana Marisa Ramos,Jayalakshmi S. Mysore,Tammy Gillis,Vanessa C. Wheeler,Marcy E. MacDonald,James F. Gusella,Branduff McAllister,Thomas Massey,Christopher Medway,Timothy Stone,Lynsey S. Hall,Lesley Jones,Peter Holmans,Seung Kwak,Anka G. Ehrhardt,Cristina Sampaio,Marc Ciosi,Alastair Maxwell,Afroditi Chatzi,Darren G. Monckton,Michael Orth,G. Bernhard Landwehrmeyer,Jane S. Paulsen,E. Ray Dorsey,Ira Shoulson,Richard H. Myers +37 more
TL;DR: Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin’s polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops.